Xeriant, Inc. announced the signing of a joint venture agreement with Movychem s.r.o. (Movychem). The definitive agreement establishes a U.S.-based partnership between Xeriant and Movychem, structured as a 50/50 joint venture, which has acquired the exclusive worldwide rights to the internationally patented, eco-friendly Retacell® fire retardant technology and is responsible for developing applications and commercializing products derived from Retacell®. The establishment of the joint venture is the culmination of several months of negotiations, which included a series of meetings in December 2021 held in the Czech Republic.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0249 USD | +18.57% | -17.00% | +40.68% |
1st Jan change | Capi. | |
---|---|---|
+40.68% | 10.58M | |
+25.65% | 139B | |
+14.02% | 80.39B | |
-4.62% | 66.06B | |
+23.64% | 52.12B | |
+50.48% | 47.53B | |
+4.06% | 40.83B | |
+77.28% | 40.53B | |
+59.32% | 25.61B | |
+80.00% | 24.18B |
- Stock Market
- Equities
- XERI Stock
- News Xeriant, Inc.
- Xeriant Signs Joint Venture Agreement with Movychem